Finnrick - Ensuring a Safer and More Transparent Supply Chain
Guangzhou Aoyu

Guangzhou Aoyu

Tirzepatide

Finnrick tested 5 samples of Tirzepatide (GLP-1 and GIP agonist) from Guangzhou Aoyu between 28 Apr 2026 and 15 Jun 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).

Finnrick Rating™
Tentative Rating
Guangzhou Aoyu
Tirzepatide
Tested 5 Samples
Last test 15 Jun 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Guangzhou Aoyu

Samples are tested in commercial labs

Tests Count

5

Scores

AVG5.8MIN0.0MAX10.0

Last

15 Jun 2026

First

28 Apr 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
15 Jun 2026View8.830mg27.4mg-8.7%99.90%Mar. 18,2026No label / Silver crimp / Gray capLab EPublic
6 Jun 2026View0.060mg
⚠️ Sample does not contain Tirzepatide
(no batch ID)No label / Silver crimp / Clear capLab GPublic
4 Jun 2026View2.020mg
⚠️ Sample does not contain Tirzepatide
June10rt10White label / Silver crimp / Clear Pink capLab GPublic
6 May 2026View8.330mg26.8mg-10.7%99.90%Feb 1, 2026White Label / Silver Crimp / Violet CapLab EPublic
28 Apr 2026View10.020mg19.9mg-0.5%99.90%1/31/26Gray Label / Silver Crimp / Yellow CapLab EPublic
Test my peptides for free